These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31542533)

  • 41. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of a strategy of image-guided left ventricular lead placement during cardiac resynchronization therapy on health care utilization.
    Rodriguez Y; Nan J; Yasin O; Gorcsan J; Saba S
    Int J Cardiol; 2015; 187():311-2. PubMed ID: 25839631
    [No Abstract]   [Full Text] [Related]  

  • 43. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease.
    Miyazaki A; Negishi J; Hayama Y; Baba S; Matsumura Y; Shima Y; Tsuda E; Sakaguchi H; Hoashi T; Kagisaki K; Noda T; Doi H; Ichikawa H; Ohuchi H
    Heart Vessels; 2019 Aug; 34(8):1340-1350. PubMed ID: 30863899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel electrocardiographic dyssynchrony criteria improve patient selection for cardiac resynchronization therapy.
    Vereckei A; Szelényi Z; Kutyifa V; Zima E; Szénási G; Kiss M; Katona G; Karádi I; Merkely B
    Europace; 2018 Jan; 20(1):97-103. PubMed ID: 28011802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tailoring device settings in cardiac resynchronization therapy using electrograms from pacing electrodes.
    Engels EB; Mafi-Rad M; Hermans BJM; Aranda A; van Stipdonk AMW; Rienstra M; Scheerder COS; Maass AH; Prinzen FW; Vernooy K
    Europace; 2018 Jul; 20(7):1146-1153. PubMed ID: 29106563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
    Feneon D; Behaghel A; Bernard A; Fournet M; Mabo P; Daubert JC; Leclercq C; Donal E
    Heart Rhythm; 2015 Aug; 12(8):1800-6. PubMed ID: 25896013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-photon cardiac imaging in patients with cardiac implantable electrical devices.
    Valzania C; Bonfiglioli R; Fallani F; Martignani C; Ziacchi M; Diemberger I; Biffi M; Fanti S; Galiè N
    J Nucl Cardiol; 2022 Apr; 29(2):633-641. PubMed ID: 33241474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling.
    Martens P; Verbrugge FH; Bertrand PB; Verhaert D; Vandervoort P; Dupont M; Tang WHW; Janssens S; Mullens W
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007813. PubMed ID: 30354673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left Ventricular Lead Placement Targeted at the Latest Activated Site Guided by Electrophysiological Mapping in Coronary Sinus Branches Improves Response to Cardiac Resynchronization Therapy.
    Liang Y; Yu H; Zhou W; Xu G; Sun YI; Liu R; Wang Z; Han Y
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1333-9. PubMed ID: 26249040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
    Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanical dyssynchrony in heart failure: Still a valid concept for optimizing treatment?
    Galli E; Leclercq C; Donal E
    Arch Cardiovasc Dis; 2017 Jan; 110(1):60-68. PubMed ID: 28065446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface electrogram-guided left ventricular lead placement improves response to cardiac resynchronization therapy.
    Şipal A; Bozyel S; Aktaş M; Derviş E; Akbulut T; Argan O; Çelikyurt U; Ural D; Şahin T; Ağır A; Vural A
    Anatol J Cardiol; 2018 Mar; 19(3):184-191. PubMed ID: 29521312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT).
    Kočková R; Sedláček K; Wichterle D; Šikula V; Tintěra J; Jansová H; Pravečková A; Langová R; Krýže L; El-Husseini W; Segeťová M; Kautzner J
    Int J Cardiol; 2018 Nov; 270():325-330. PubMed ID: 29908832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac resynchronization therapy in adults with congenital heart disease.
    Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L
    Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differentiating Electromechanical From Non-Electrical Substrates of Mechanical Discoordination to Identify Responders to Cardiac Resynchronization Therapy.
    Lumens J; Tayal B; Walmsley J; Delgado-Montero A; Huntjens PR; Schwartzman D; Althouse AD; Delhaas T; Prinzen FW; Gorcsan J
    Circ Cardiovasc Imaging; 2015 Sep; 8(9):e003744. PubMed ID: 26338877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
    Nakata T; Hashimoto A; Wakabayashi T; Kusuoka H; Nishimura T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1393-400. PubMed ID: 20083074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.